Human immunodeficiency virus 1 (HIV-1) envelope-dependent cell-cell fusion modulation by HIV-positive sera is related to disease progression

Journal of General Virology

Volumn 86, Issue 7, 2005, Pages 1961-1966

  Huerta, L ^a   Gomez Icazbalceta G ^a   Soto Ramirez L ^b   Viveros Rogel, M ^b   Rodriguez R ^b   Fuentes, L ^b   Lamoyi, E ^a   Larralde, C ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY PRODUCTION; ARTICLE; CELL DAMAGE; CELL FUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; LYMPHOCYTE COUNT; MODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; VIRUS ENVELOPE; VIRUS LOAD; VIRUS TRANSMISSION;

CELL FUSION; DISEASE PROGRESSION; GENE PRODUCTS, ENV; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 21444447467     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80635-0     Document Type: Article

References (41)

1. Allaway, G. P., Ryder, A. M., Beaudry, G. A. & Maddon, P. J. (1993). Synergistic inhibition of HIV-1 envelope-mediated cell fusion by CD4-based molecules in combination with antibodies to gp120 or gp41. AIDS Res Hum Retroviruses 9, 581-587.
2. + T lymphocytes and accessory cells in lymphoid tissues. Proc Natl Acad Sci U S A 93, 11057-11062.
3. Asherson, R. A. & Shoenfeld, V. (2003). Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome. J Rheumatol 30, 214-219.
4. + T cell decline. Proc Natl Acad Sci U S A 97, 1269-1274.
5. Budka, H. (1986). Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS). Acta Neuropathol 69, 253-258.
6. Cao, J., Park, I. W., Cooper, A. & Sodroski, J. (1996). Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1. J Virol 70, 1340-1354.
7. Castedo, M., Roumier, T., Blanco, J. & 18 other authors (2002). Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope. EMBO J 21, 4070-4080.
8. Castro, K. G., Ward, J. W., Slutsker, L., Buehler, J. W., Jaffe, H. W. & Berkelman, R. L. (1993). Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid Mortal Wkly Rep 41, 1-19.
9. Cecilia, D., Kleeberger, C., Muñoz, A., Giorgi, J. V. & Zolla-Pazner, S. (1999). A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects. J Infect Dis 179, 1365-1374.
10. Connor, R. I. & Ho, D. D. (1994). Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol 68, 4400-4408.
11. Connor, R. I., Mohri, H., Cao, Y. & Ho, D. D. (1993). Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 67, 1772-1777.
12. + T-cell depletion in macaques infected by a simian-human immunodeficiency virus. J Virol 75, 5646-5655.
13. Ferri, K. F., Jacotot, E., Blanco, J. & 8 other authors (2000). Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases. J Exp Med 192, 1081-1092.
14. Frankel, S. S., Wenig, B. M., Burke, A. P., Manan, P., Thompson, L. D., Abbondazo, S. L., Nelson, A. M., Pope, M. & Steinman, R. M. (1996). Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 272, 115-117.
15. Gudiño, J. C. & Soler, C. (2000). Detección de virus subtipo B del HIV-1 mediante el análisis de restricción de amplicones de gag con la enzima Bst Xi (REA-PCR). Abstracts from the I Congreso Nacional de la Rama de Bioquímica y Biología Molecular de Virus de la Sociedad Mexicana de Bioquímica. Rev Biomed 11, 135-154.
16. Gummurulu, S., Kinsey, M. C. & Emerman, M. (2000). An in vitro rapid-turnover assay for human immunodeficiency virus type 1 replication selects for cell-to-cell spread of virus. J Virol 74, 10882-10891.
17. Gupta, P., Balachandran, R., Ho, M., Enrico, A. & Rinaldo, C. (1989). Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody. J Virol 63, 2361-2365.
18. Hioe, C. E., Bastiani, L., Hildreth, J. E. & Zolla-Pazner, S. (1998). Role of cellular adhesion molecules in HIV type 1 infection and their impact on virus neutralization. AIDS Res Hum Retroviruses 14, S247-S254.
19. Huerta, L., Lamoyi, E., Báez-Saldaña, A. & Larralde, C. (2002). Human immunodeficiency virus envelope-dependent cell-cell fusion: a quantitative fluorescence cytometric assay. Cytometry 47, 100-106.
20. Kilby, J. M., Hopkins, S., Venetta, T. M. & 12 other authors (1998). Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med 4, 1302-1307.
21. Koenig, S., Gendelman, H. E., Orenstein, J. M. & 7 other authors (1986). Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233, 1089-1093.
22. Laurent-Crawford, A. G., Krust, B., Muller, S., Riviere, Y., Rey-Cuille, M. A., Bechet, J. M., Montagnier, L. & Hovanessian, A. G. (1991). The cytopathic effect of HIV is associated with apoptosis. Virology 185, 829-839.
23. Lazzarin, A., Clotet, B., Cooper, D. & 14 other authors (2003). Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia. N Engl J Med 348, 2186-2219.
24. Lifson, J. D., Feinberg, M. B., Reyes, G. R. & 7 other authors (1986). Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature 323, 725-728.
25. McKeating, J. A., Zhang, Y. J., Arnold, C., Frederiksson, R., Fenyo, E.-M. & Balfe, P. (1996). Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type 1 show increased sensitivity to neutralization by human sera. Virology 220, 450-460.
26. Miedema, F., Meyaard, L., Koot, M. & 11 other authors (1994). Changing virus-host interactions in the course of HIV-1 infection. Immunol Rev 140, 35-72.
27. Montefiori, D. C., Pantaleo, G., Fink, L. M., Zhou, J. T., Zhou, J. Y., Bilska, M., Miralles, G. D. & Fauci, A. S. (1996). Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long term nonprogressors. J Infect Dis 173, 60-67.
28. Muller, C., Kukel, S., Schneweis, K. E. & Bauer, R. (1994). Anti-lymphocyte antibodies in plasma of HIV-1-infected patients preferentially react with MHC class II-negative T cells and are linked to antibodies against gp41. Clin Exp Immunol 97, 367-372.
29. Ngo-Giang-Huong, N., Candotti, D., Goubar, A. & 8 other authors (2001). HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression. AIDS Res Hum Retroviruses 17, 1435-1446.
30. Pantaleo, G., Demarest, J. F., Vaccareza, M., Graziosi, C., Bansal, G. P., Koenig, S. & Fauci, A. S. (1995). Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission. Eur J Immunol 25, 226-231.
31. Phillips, D. M. (1994). The role of cell-to-cell transmission in HIV infection. AIDS 8, 719-731.
32. Pilgrim, A. K., Pantaleo, G., Cohen, O. J., Fink, L. M., Zhou, J. Y., Zhou, J. T., Bolognesi, D. P., Fauci, A. S. & Montefiori, D. C. (1997). Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J Infect Dis 176, 924-932.
33. Poignard, P., Sabbe, R., Picchio, G. R., Wang, M., Gulizia, R. J., Katinger, H., Parren, P. W. H. I., Mosier, D. E. & Burton, D. R. (1999). Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity 10, 431-438.
34. Posner, M. R., Hideshima, T., Cannon, T., Mukherjee, M., Mayer, K. H. & Byrn, R. A. (1991). An IgG human monoclonal antibody that reacts with HIV-1/gp120, inhibits virus binding to cells, and neutralizes infection. J Immunol 146, 4325-4332.
35. Robert-Guroff, M., Goedert, J. J., Naugle, C. J., Jenning, A. M., Blattner, W. A. & Gallo, R. C. (1988). Spectrum of HIV-1 neutralizing antibodies in a cohort of homosexual men: results of a 6 year prospective study. AIDS Res Hum Retroviruses 4, 343-350.
36. Sato, H., Orenstein, J., Dimitrov, D. & Martin, M. (1992). Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology 186, 712-724.
37. Sekigawa, I., Groopmen, J. E., Allan, J. D., Ikeuchi, K., Biberfield, G., Takatsuki, K. & Byrn, R. A. (1991). Characterization of autoantibodies to the CD4 molecule in human immunodeficiency virus infection. Clin Immunol Immunopathol 58, 145-153.
38. Sodroski, J., Goh, W. C., Rosen, C., Campbell, K. & Haseltine, W. A. (1986). Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 322, 470-474.
39. Trkola, A., Ketas, T., Kewalramani, V. N., Endorf, F., Binley, J. M. & Katinger, H. (1998). Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage. J Virol 72, 1876-1885.
40. WHO (2001). Monitoring the emergence of antiretroviral resistance. Report of a WHO consultation in collaboration with Instituto di Sanitá and the Internationl AIDS Society. WHO/CDS/CSR/DRS /2001.11. World Health Organization.
41. Zwick, M. B., Wang, M., Poignard, P., Stiegler, G., Katinger, H., Burton, D. R. & Parren, P. W. (2001). Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies. J Virol 75, 12198-12208.